Cytosorbents Corp Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cytosorbents Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Cytosorbents Corp Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 54.5M shares, a 24.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 54.5M +10.6M +24.3% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 54.3M +10.5M +23.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 54.3M +10.4M +23.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 54.2M +10.6M +24.3% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 43.9M +217K +0.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 43.9M +277K +0.64% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 43.9M +345K +0.79% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 43.6M 0 0% Dec 31, 2022 10-K 2024-03-15
Q3 2022 43.6M +159K +0.37% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 43.6M +237K +0.55% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 43.5M +234K +0.54% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 43.6M +414K +0.96% Dec 31, 2021 10-K 2023-03-09
Q3 2021 43.5M +300K +0.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 43.3M +6.53M +17.7% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 43.3M +7.14M +19.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 43.2M +10.6M +32.5% Dec 31, 2020 10-K 2022-03-10
Q3 2020 43.2M +10.8M +33.2% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 36.8M +4.51M +14% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 36.1M +3.89M +12.1% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 32.6M +842K +2.65% Dec 31, 2019 10-K 2021-03-09
Q3 2019 32.4M +789K +2.49% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 32.3M +885K +2.82% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 32.2M +2.27M +7.57% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 31.8M +2.8M +9.67% Dec 31, 2018 10-K 2020-03-05
Q3 2018 31.6M +3.15M +11.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 31.4M +3.28M +11.7% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 30M +4.42M +17.3% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 29M +3.49M +13.7% Dec 31, 2017 10-K 2019-03-07
Q3 2017 28.5M +3.01M +11.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 28.1M +2.7M +10.6% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 25.6M +147K +0.58% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 25.5M +86.9K +0.34% Dec 31, 2016 10-K 2018-03-08
Q3 2016 25.5M +292K +1.16% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 25.4M +547K +2.2% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 25.4M +728K +2.95% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 25.4M +2.09M +8.98% Dec 31, 2015 10-K 2017-03-03
Q3 2015 25.2M -298M -92.2% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 24.9M -286M -92% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 24.7M -274M -91.7% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 23.3M +13.3M +132% Dec 31, 2014 10-K 2016-03-09
Q3 2014 323M +77.6M +31.7% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 310M +76M +32.4% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 299M +70.1M +30.6% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 10.1M -205M -95.3% Dec 31, 2013 10-K 2015-03-31
Q3 2013 245M +35.2M +16.8% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 234M +35.3M +17.8% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 229M +39.1M +20.6% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 215M +37.3M +21% Dec 31, 2012 10-K 2014-03-31
Q3 2012 210M +37.6M +21.8% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 199M +33.2M +20% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 190M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 178M +54.8M +44.6% Dec 31, 2011 10-K 2013-04-03
Q3 2011 172M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 166M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 123M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.